
Mettler-Toledo International MTD
€ 896.78
0.19%
Quartalsbericht 2026-Q1
hinzugefügt 08.05.2026
Mettler-Toledo International P/CF 2011-2026 | MTD
P/CF Jährlich Mettler-Toledo International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29.7 | 30.9 | 26.6 | 39.5 | 37.5 | 38.5 | 37.7 | 37.8 | 44.8 | 35.1 | 25.1 | 26.6 | 28.3 | 28.3 | 30.8 | 13.9 | 10.9 | 15.9 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 44.8 | 10.9 | 29.9 |
P/CF anderer Aktien in der Diagnostik & Forschung
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 17.26 | -7.0 % | $ 181 M | ||
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Co-Diagnostics
CODX
|
-0.201 | $ 1.34 | -17.79 % | $ 1.78 M | ||
|
Fulgent Genetics
FLGT
|
22.2 | $ 15.78 | -2.53 % | $ 477 M | ||
|
Agilent Technologies
A
|
28.3 | $ 112.09 | -1.02 % | $ 34.1 B | ||
|
Castle Biosciences
CSTL
|
7.33 | $ 19.05 | 0.9 % | $ 552 M | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
Illumina
ILMN
|
19.6 | $ 139.97 | -2.28 % | $ 22.3 B | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
Interpace Biosciences
IDXG
|
1.26 | $ 1.8 | -5.26 % | $ 7.96 M | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 19.83 | -3.22 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 94.74 | -2.0 % | $ 6.39 B | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 419.82 | 0.16 % | $ 12.1 B | ||
|
Myriad Genetics
MYGN
|
227 | $ 3.6 | -0.69 % | $ 333 M | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
NeoGenomics
NEO
|
284 | $ 8.28 | -0.96 % | $ 1.06 B | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
11.9 | $ 18.46 | -2.48 % | $ 413 M | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 157.18 | -1.33 % | $ 7.79 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Natera
NTRA
|
-12.3 | $ 186.22 | -5.43 % | $ 18.3 B | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 25.27 | -0.94 % | $ 24 B | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Guardant Health
GH
|
-72.7 | $ 92.95 | -5.79 % | $ 11.7 B | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 5.73 | -1.55 % | $ 239 M | ||
|
Personalis
PSNL
|
-5.75 | $ 6.47 | -3.64 % | $ 577 M | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 117.95 | 0.73 % | $ 9.73 B | ||
|
Soleno Therapeutics
SLNO
|
44.5 | $ 52.99 | -0.01 % | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Twist Bioscience Corporation
TWST
|
-32.8 | $ 49.3 | -6.89 % | $ 2.95 B | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.31 | -4.04 % | $ 5.31 M | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 251.18 | -1.12 % | $ 20.9 B | ||
|
Thermo Fisher Scientific
TMO
|
25.1 | $ 439.31 | -1.97 % | $ 166 B | ||
|
Trinity Biotech plc
TRIB
|
-46.3 | $ 0.57 | -1.49 % | $ 205 M | ||
|
Celcuity
CELC
|
-35 | $ 134.9 | 0.13 % | $ 6.31 B | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
30.1 | $ 331.34 | -0.56 % | $ 19.7 B | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 8.27 | -1.9 % | $ 1.79 B |